Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 405

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 1
Chunk 405
---
December 31, 2024 is summarized below:

Schedule
of warrant activity

    Weighted  

    Weighted  
    Average  

    Number of  
     Average
 Exercise  
    Remaining
 Contractual  
    Aggregate 

     Warrants  
     Price  
    Term (Years)  
    Intrinsic Value 
  
    Balance Outstanding as January 1, 2023 
     -  
    $-  
     -  
     - 
  
    Granted 
     2,774,057  
    $4.85  
     5.0 (1) 
             - 
  
    Balance Outstanding as December 31, 2023 
     2,774,057  
    $4.85  
     4.5 (1) 
     - 
  
    Granted 
     50,000  
    $7.00  
     3.2  
     - 
  
    Exercised 
     (10,000) 
    $3.73  
     -  
     - 
  
    Balance Outstanding as December 31, 2024 
     2,814,057  
    $4.97  
     3.49 (2) 
     - 
  
    Exercisable, December 31, 2024 
     2,814,057  
    $4.97  
     3.49 (2) 
     - 

(1)The
warrants herein consist of various contractual terms. The warrants herein consist of 2,439,025
warrants issued to Bay Shore
Trust that have a remaining contractual term of 4.5
years as of December 31, 2023,
and 335,032
warrants issued to investors
associated with the 2023 Private Placement that currently have an indeterminable contractual term. See disclosures below for more information
on these warrants

(2)The warrants herein
consist of various contractual terms. The warrants herein consist of 2,429,025 warrants issued to Bay Shore Trust that have a remaining
contractual term of 3.5 years as of December 31, 2024, 335,032 warrants issued to investors associated with the 2023 Private Placement
that currently have an indeterminable contractual term, and